Cgmp manufacture of VHCA8* for the treatment of pain
Active Awarded Last action
- Contract number
- 75N95024F00002
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $11,506,045
Award facts
- Opportunity
-
- 75N95024R00026 Solicitation number
- Contract value 76% obligated
-
- $11,506,044.62 Current, with exercised options
- $15,215,773.62 Potential, with all options
- Completion date 89% complete
- Current and potential, with all options
- NAICS code
- 541512 Computer Systems Design Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $2,165,951 | |
| Exercise an Option | $3,050,611 | |
| Exercise an Option | $679,987 | |
| Change Order | $65,015 | |
| Exercise an Option | $3,567,118 | |
| Original award | $1,977,362 |
About this award
The National Institute on Drug Abuse issued a delivery order to Advanced Bioscience Laboratories, Inc. on September 30, 2022, with a ceiling value of $15.2 million under the Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products for Neurological-related Disorders IDIQ for current good manufacturing practice (CGMP) manufacture of VHCA8 for pain treatment.
Place of performance is Rockville, MD. The order carries an ultimate completion date of April 29, 2027, and is structured as cost-plus-fixed-fee with no set-aside applied.
Government-invoiced labor through fiscal 2025 totaled $832 thousand against 0.3 FTEs. In fiscal 2024, the order consumed 1,942 contractor hours at a derived rate of $411.93 per hour across 0.9 FTEs. Advanced Bioscience Laboratories performed all reported work without subcontractor engagement.
Quick answers
Who was awarded contract 75N95024F00002?
75N95024F00002 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 30, 2022.
How much is contract 75N95024F00002 worth?
The government has obligated $11,506,045 on 75N95024F00002. Its potential value, with all options, is $15,215,774.
Is contract 75N95024F00002 an order under another contract?
Yes. 75N95024F00002 is a delivery order under 75N95022D00023, an indefinite delivery contract, on Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products for Neurological-related Disorders.
Was contract 75N95024F00002 competed?
The extent of competition for 75N95024F00002 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award